Primex, the leading provider of Internet of Medical Things (IoMT) environmental monitoring technologies, today announced its OneVue Sense™ temperature sensor and automated monitoring platform can help labs, pharmacies, hospitals, and other vaccine administrators across the healthcare industry prepare for the pending global rollout of COVID-19 vaccines. The integrated system is authorized to meet expected guidelines set by the U.S. Centers for Disease Control and Prevention (CDC) and other governing bodies.
The current leading COVID-19 vaccine candidates are expected to require extremely cold storage temperatures, with some as low as minus 94 degrees Fahrenheit (minus 70 degrees Celsius). A Primex OneVue Sense temperature sensor with cryogenic probe can monitor storage units as low as minus 328 degrees Fahrenheit (minus 200 degrees Celsius). When paired with the OneVue Monitor™ automated monitoring software solution, the integrated system provides real-time alerts if vaccine storage temperatures fluctuate outside of the specified temperature range, helping maintain vaccine safety and effectiveness. The system also archives all recorded temperatures to ensure compliance.
“Any breach in temperature control can degrade a vaccine, making it lose its full potency,” said Paul Shekoski, CEO for Primex. “With the Primex OneVue platform, customers have peace of mind knowing that the vaccine will always remain at the proper temperature.”
In addition to temperature, functionalities within OneVue include indoor air quality, differential pressure, and contact closure monitoring solutions, which can be used in hospital isolation rooms and to ensure freezer storage doors remain closed. The cloud-based software in OneVue is fully customizable, enabling users to schedule reports, alerts, and messaging to suit their specific needs and synchronize many different types of devices across a facility. There are over 40,000 Primex sensors installed in healthcare settings around the country.
“For nearly 50 years, healthcare providers have trusted Primex to deliver proven and reliable healthcare solutions,” said Shekoski. “We are proud to be part of this monumental public health effort to ensure safe, reliable, and effective COVID-19 vaccines reach the public.”
